Skip to main content
. 2021 Apr 25;23(10):1612–1676. doi: 10.1093/europace/euab065

VTE prevention post-major orthopaedic surgery

Standard dose Comments/dose reduction
Apixaban507 2.5 mg BID
Dabigatran508,509 220 mg QD/150 mg QD a
Edoxaban510,511 30 mg QD Not approved in Europe (only studied in Asia)
Rivaroxaban512–515 10 mg QD

BID, twice daily; QD, once daily.

a

SmPc: 1× 150 mg if CrCl 30–50 mL/min; concomitant verapamil, amiodarone, quinidine; age >75 years.